Marta Roncetti

Marta Roncetti

Auto-generated profile, based on publicly available information

Marta Roncetti

Institute of Clinical Physiology (IFC), Italian National Research Council (CNR), Via Moruzzi 1, 56124 Pisa, Italy

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in ACS Chemical Biology
Verified
Journal Article
Open access
ILIrene Lepori
Irene Lepori
MRMarta Roncetti
Marta Roncetti
MVMARIANNA Vitiello
MARIANNA Vitiello
EBelisabetta barresi
elisabetta barresi
RPRaffaella De Paolo
Raffaella De Paolo
Laura PolisenoLaura Poliseno
Laura Poliseno
Among bacteria used as anticancer vaccines, attenuated Listeria monocytogenes (Lmat) stands out, because it spreads from one infected cancer cell to the next, induces a strong adaptive immune response, and is suitable for repeated injection cycles. Here, we use click chemistry to functionalize the Lmat cell wall and turn the bacterium into an "intelligent carrier" of the chemotherapeutic drug doxorubicin. Doxorubicin-loaded Lmat retains most of its biological properties and, compared to the control fluorophore-functionalized bacteria, shows enhanced cytotoxicity against melanoma cells both in vitro and in a xenograft model in zebrafish. Our results show that drugs can be covalently loaded on the Lmat cell wall and pave the way to the development of new two-in-one therapeutic approaches combining immunotherapy with chemotherapy.

Verified
Journal Article
Open access
PDF file
LPLucrezia Paradisi
Lucrezia Paradisi
PGPaolo Guazzi
Paolo Guazzi
MMMatteo Macis
Matteo Macis
FFFrancesca Finetti
Francesca Finetti
ATAlfonso Trezza
Alfonso Trezza
Lorenza TrabalziniLorenza Trabalzini
Lorenza Trabalzini
K-Rev Interaction Trapped protein-1 (KRIT1) is a scaffold protein that forms functional protein complexes involved in physiologically important signaling networks. While it is primarily recognized for its association with Cerebral Cavernous Malformations (CCMs), KRIT1 may also play critical roles in tumor formation and the acquisition of malignant phenotypes, regulating cell adhesion, cytoskeletal dynamics, and angiogenesis. In this study, we investigated the role of KRIT1 in cancer cell migration and metastasis, with a focus on identifying novel interacting proteins and characterizing the intracellular signaling pathways activated upon its loss. By using a yeast two-hybrid screening, we identified Kinesin Family Member 1C (KIF1C), a protein involved in regulating podosome and invadopodium elongation, as a novel binding partner of KRIT1, and the interaction was confirmed in melanoma and epithelial cancer cells. In silico docking and interaction interface analyses supported the KRIT1–KIF1C interaction, providing structural insight into the binding mode as shown experimentally. We also found that SRC and focal adhesion kinase (FAK) phosphorylation, as well as Ras homolog family member A (RhoA) expression, represent additional pathways affected by the loss of KRIT1. This study confirms our earlier hypothesis that KRIT1 functions as a tumor suppressor and uncovers a compelling link between its loss and enhanced cancer aggressiveness.